Corline Biomedical AB
SSE:CLBIO.ST
13.8 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.255 | 3.738 | 6.244 | 5.31 | 6.078 | 7.398 | 8.245 | 7.028 | 5.207 | 3.07 | 3.24 | 0.962 | 1.326 | 1.534 | 2.536 | 0.368 | 0.601 | 0.191 | 0.417 | 0.138 | 0.369 | 0.14 | 0.545 | 0.362 | 0.346 | 0.31 | 0.196 | 0.122 | 0.103 | 0.217 | 0.206 | 0.158 | 0.367 | 0.218 | 0.15 | 0.232 | 0.543 | 0.112 | 0.677 | 0.26 | 0.494 |
| Cost of Revenue
| 6.652 | 5.444 | 6.265 | -1.891 | 0.603 | -1.099 | 1.153 | 0.086 | -0.117 | -0.298 | -0.39 | -0.559 | -0.313 | -0.778 | -1.842 | -0.556 | -1.931 | -2.295 | -2.041 | -1.164 | -1.665 | -1.213 | -6.006 | 0.606 | 0.436 | -0.002 | 0.146 | 0.045 | -0.623 | -0.513 | -0.894 | -1.673 | -2.172 | -1.763 | -0.654 | -0.499 | -0.605 | -0.405 | -0.354 | -0.455 | -0.434 |
| Gross Profit
| -4.397 | -1.706 | -0.021 | 7.201 | 5.475 | 8.497 | 7.092 | 6.942 | 5.324 | 3.368 | 3.63 | 1.521 | 1.639 | 2.312 | 4.378 | 0.924 | 2.532 | 2.486 | 2.458 | 1.302 | 2.034 | 1.353 | 6.551 | -0.244 | -0.09 | 0.312 | 0.05 | 0.077 | 0.726 | 0.73 | 1.1 | 1.831 | 2.539 | 1.981 | 0.804 | 0.731 | 1.148 | 0.518 | 1.031 | 0.716 | 0.929 |
| Gross Profit Ratio
| -1.95 | -0.456 | -0.003 | 1.356 | 0.901 | 1.149 | 0.86 | 0.988 | 1.022 | 1.097 | 1.12 | 1.581 | 1.236 | 1.507 | 1.726 | 2.511 | 4.213 | 13.016 | 5.894 | 9.435 | 5.512 | 9.664 | 12.02 | -0.674 | -0.26 | 1.006 | 0.255 | 0.631 | 7.049 | 3.364 | 5.34 | 11.589 | 6.918 | 9.101 | 5.365 | 3.156 | 2.113 | 4.613 | 1.523 | 2.75 | 1.879 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.295 | 1.919 | 1.771 | 0 | 1.513 | 1.611 | 1.65 | -0.859 | 1.442 | 2.918 | 2.717 | 0 | 1.18 | 1.946 | 1.699 | 1.802 | 1.018 | 1.368 | 1.261 | 5.016 | 1.983 | 2.079 | 2.866 | 1.596 | 1.767 | 1.783 | 1.768 | 0.633 | 0.575 | 0.68 | 0.65 | 0.242 | 0.314 | 0.455 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.849 | 6.587 | 7.204 | 6.699 | 7.445 | 7.395 | 7.183 | 2.295 | 1.919 | 1.771 | 4.944 | 1.513 | 1.611 | 1.65 | -0.859 | 1.442 | 2.918 | 2.717 | 4.583 | 1.18 | 1.946 | 1.699 | 1.802 | 1.018 | 1.368 | 1.261 | 5.016 | 1.983 | 2.079 | 2.866 | 1.596 | 1.767 | 1.783 | 1.768 | 0.633 | 0.575 | 0.68 | 0.65 | 0.242 | 0.314 | 0.455 |
| Other Expenses
| -0.006 | 0 | 0 | 0 | 0 | 7.478 | 6.753 | 2.681 | 2.53 | 2.449 | 0.042 | 2.083 | 2.169 | 2.067 | 5.292 | 1.632 | 2.189 | 2.276 | 4.574 | 2.054 | 2.613 | 2.621 | 6.418 | 0.208 | 0.412 | 0.834 | -3.267 | -0.919 | 0.684 | 0.949 | 1.028 | 1.378 | 1.357 | 1.992 | 2.211 | 1.222 | 1.903 | 0.975 | 1.354 | 1.021 | 1.004 |
| Operating Expenses
| 9.843 | 6.573 | 7.81 | 6.997 | 7.883 | 7.478 | 6.753 | 4.976 | 4.449 | 4.22 | 0.042 | 3.596 | 3.78 | 3.717 | 4.433 | 3.074 | 5.107 | 4.993 | 4.574 | 3.234 | 4.559 | 4.32 | 8.22 | 1.226 | 1.78 | 2.095 | 1.749 | 1.064 | 2.763 | 3.815 | 2.624 | 3.145 | 3.14 | 3.762 | 2.844 | 1.797 | 2.582 | 1.625 | 1.595 | 1.335 | 1.46 |
| Operating Income
| -4.397 | -1.706 | -0.021 | 0.204 | -2.408 | 1.019 | 0.339 | 1.966 | 0.875 | -0.852 | -1.288 | -2.075 | -2.141 | -1.405 | -0.055 | -2.15 | -2.575 | -2.507 | -2.116 | -1.932 | -2.525 | -2.967 | -1.669 | -1.47 | -1.87 | -1.783 | -1.7 | -0.987 | -2.037 | -3.085 | -1.524 | -1.314 | -0.601 | -1.781 | -2.068 | -1.066 | -1.434 | -1.108 | -0.564 | -0.62 | -0.531 |
| Operating Income Ratio
| -1.95 | -0.456 | -0.003 | 0.038 | -0.396 | 0.138 | 0.041 | 0.28 | 0.168 | -0.278 | -0.398 | -2.157 | -1.615 | -0.916 | -0.022 | -5.842 | -4.285 | -13.126 | -5.074 | -14 | -6.843 | -21.193 | -3.062 | -4.061 | -5.405 | -5.752 | -8.673 | -8.09 | -19.777 | -14.217 | -7.398 | -8.316 | -1.638 | -8.184 | -13.799 | -4.605 | -2.639 | -9.87 | -0.833 | -2.381 | -1.075 |
| Total Other Income Expenses Net
| 0.028 | 0.038 | -0.579 | -0.025 | 0.001 | 0.001 | 0.445 | -0.058 | 0.102 | 0.06 | 0.038 | -0.001 | -0.012 | -0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | -0.001 | 0 | -0.001 | 0 | -0.001 | 0 | 0.026 | -0.054 | -0.188 | -0.002 | -0.003 | -0.004 | 0.009 | -0.007 | -0.002 |
| Income Before Tax
| -4.369 | -1.668 | -0.6 | 0.179 | -2.407 | 1.02 | 0.339 | 1.966 | 0.875 | -0.852 | -1.288 | -2.076 | -2.153 | -1.405 | -0.055 | -2.15 | -2.575 | -2.507 | -2.116 | -1.932 | -2.525 | -2.967 | -1.669 | -1.47 | -1.87 | -1.784 | -1.7 | -0.987 | -2.038 | -3.085 | -1.524 | -1.314 | -0.575 | -1.835 | -2.228 | -1.068 | -1.437 | -1.112 | -0.555 | -0.627 | -0.533 |
| Income Before Tax Ratio
| -1.937 | -0.446 | -0.096 | 0.034 | -0.396 | 0.138 | 0.041 | 0.28 | 0.168 | -0.278 | -0.398 | -2.158 | -1.624 | -0.916 | -0.022 | -5.842 | -4.285 | -13.126 | -5.074 | -14 | -6.843 | -21.193 | -3.062 | -4.061 | -5.405 | -5.755 | -8.673 | -8.09 | -19.786 | -14.217 | -7.398 | -8.316 | -1.567 | -8.43 | -14.869 | -4.613 | -2.645 | -9.904 | -0.819 | -2.409 | -1.079 |
| Income Tax Expense
| 0 | -0.021 | 0 | 0.001 | 0.001 | -0.001 | 0.445 | -0.058 | 0.102 | 0.06 | 0.038 | 0 | 0 | -0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | -0.028 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -4.369 | -1.668 | -0.6 | 0.179 | -2.407 | 1.02 | 0.339 | 1.966 | 0.875 | -0.852 | -1.288 | -2.076 | -2.153 | -1.405 | -0.055 | -2.15 | -2.575 | -2.507 | -2.116 | -1.932 | -2.525 | -2.967 | -1.669 | -1.47 | -1.87 | -1.784 | -1.7 | -0.987 | -2.038 | -3.085 | -1.524 | -1.314 | -0.575 | -1.835 | -2.228 | -1.068 | -1.437 | -1.112 | -0.555 | -0.627 | -0.533 |
| Net Income Ratio
| -1.937 | -0.446 | -0.096 | 0.034 | -0.396 | 0.138 | 0.041 | 0.28 | 0.168 | -0.278 | -0.398 | -2.158 | -1.624 | -0.916 | -0.022 | -5.842 | -4.285 | -13.126 | -5.074 | -14 | -6.843 | -21.193 | -3.062 | -4.061 | -5.405 | -5.755 | -8.673 | -8.09 | -19.786 | -14.217 | -7.398 | -8.316 | -1.567 | -8.43 | -14.869 | -4.613 | -2.645 | -9.904 | -0.819 | -2.409 | -1.079 |
| EPS
| -0.2 | -0.078 | -0.028 | 0.008 | -0.11 | 0.048 | 0.016 | 0.092 | 0.041 | -0.04 | -0.063 | -0.1 | -0.1 | -0.08 | -0.003 | -0.13 | -0.15 | -0.15 | -0.12 | -0.11 | -0.16 | -0.19 | -0.1 | -0.094 | -0.12 | -0.12 | -0.13 | -0.074 | -0.16 | -0.24 | -0.12 | -0.1 | -0.047 | -0.19 | -0.23 | -0.11 | -0.16 | -0.11 | -0.083 | -0.094 | -0.08 |
| EPS Diluted
| -0.2 | -0.078 | -0.028 | 0.008 | -0.11 | 0.048 | 0.016 | 0.092 | 0.041 | -0.04 | -0.063 | -0.097 | -0.1 | -0.08 | -0.003 | -0.13 | -0.15 | -0.15 | -0.12 | -0.11 | -0.15 | -0.18 | -0.1 | -0.091 | -0.12 | -0.12 | -0.13 | -0.074 | -0.16 | -0.24 | -0.12 | -0.1 | -0.047 | -0.19 | -0.22 | -0.11 | -0.16 | -0.11 | -0.083 | -0.063 | -0.054 |
| EBITDA
| -4.374 | -1.684 | 0.003 | 0.23 | -2.382 | 1.043 | 0.354 | 1.982 | 0.888 | -0.84 | -1.276 | -2.061 | -2.138 | -1.403 | -0.048 | -2.148 | -2.572 | -2.505 | -2.114 | -1.93 | -2.522 | -2.965 | -1.669 | -1.47 | -1.87 | -1.783 | -1.7 | -0.986 | -2.037 | -3.085 | -1.524 | -1.314 | -0.6 | -1.781 | -2.068 | -1.058 | -1.417 | -1.107 | -0.546 | -0.62 | -0.525 |
| EBITDA Ratio
| -1.94 | -0.451 | 0 | 0.043 | -0.392 | 0.141 | 0.043 | 0.282 | 0.171 | -0.274 | -0.394 | -2.142 | -1.612 | -0.915 | -0.019 | -5.837 | -4.28 | -13.115 | -5.07 | -13.986 | -6.835 | -21.179 | -3.062 | -4.061 | -5.405 | -5.752 | -8.673 | -8.082 | -19.777 | -14.217 | -7.398 | -8.316 | -1.635 | -8.182 | -13.798 | -4.568 | -2.608 | -9.866 | -0.806 | -2.381 | -1.063 |